The MiniMed Go™ system is cleared for individuals with insulin-requiring type 1 and type 2 diabetes aged 7 years and older, ...
Medtronic has received US Food and Drug Administration (FDA) 510 (k) clearance for its MiniMed Go Smart MDI system, a ...
Medtronic (NYSE:MDT) announced today that the FDA granted 510(k) clearance for its MiniMed Go app for multiple daily ...
Medtronic Diabetes has expanded U.S. pharmacy formulary access for its MiniMed 780F insulin pump through agreements with ...
GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones ...
Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced the U.S. Food ...
A new real-world retrospective analysis published in Diabetes Care showed that users of the MiniMed™ 780G system achieved American Diabetes Association (ADA) recommended goals for time-in-range (TIR)— ...